Publications
The Case for Tightening E-Cigarette Regulations in Southeast Asia
E-cigarette use is controversial in terms of its safety, efficacy as an aid to smoking cessation, and potential as a gateway into smoking, especially for youth. Policy responses vary considerably among countries — ranging from the precautionary implementation of a complete ban, to regulation of marketing and access, to promotion as a harm reductive alternative or effective cessation aid. This paper examines the e-cigarette situation in Southeast Asia (defined as the geographical region that includes Singapore, Indonesia, Malaysia, the Philippines, Myanmar, Thailand, Cambodia, Vietnam, Laos, Brunei, Taiwan, and Hong Kong).
Evidence-Based Policy: The Role of Academic-Government Partnership
Public health challenges are increasingly complex, multifaceted, unpredictable and diverse, with a myriad of information and viewpoints that weigh-in on policy considerations. This paper discusses how active academic-government collaborations can contribute to the relevant use of evidence for prudent public health policy development.
Today's Challenges in Outbreak Preparedness: The Role of Surveillance
Rapid trans boundary spread of infectious diseases, emerging infectious diseases, rising antimicrobial-drug resistance and the threat of bioterrorism are some of today’s most pressing global health security issues. Getting the basics right for infectious disease surveillance is now more pertinent than ever before. Yet in order for a surveillance system to continue to be effective, it needs to evolve to meet current and foreseeable challenges.
Part of: Progress in Outbreak Preparedness: The Tasks Ahead (Click here to watch on YouTube)
Trends in Gastrointestinal Endoscopy in Singapore 2014-2019
By Tan Si Ying, Rowena Yap, Bob Ng, Associate Professor Jason Yap and Associate Professor Jeremy Lim
NUS SSHSPH analysed a total of 212,793 episodes of gastrointestinal (GI) endoscopy (upper and lower GI endoscopies with and without biopsies, polypectomies etc) for the period 2014-2019. The data was obtained from seven MediShield Life Integrated Plan insurers and independently analysed for trends in utilisation, pricing and diagnoses. The highlights from the analyses are presented here.